The mycotoxin deoxynivalenol (DON) has been shown to inhibit ovarian granulosa cell function in cattle in vitro, but it is not known whether DON or its metabolite deepoxy-DON (DOM-1) affects theca cell function. The objectives of this study were to determine the effects of DON and of DOM-1 on theca cell steroidogenesis and apoptosis, and to determine the main pathways through which they act. Bovine theca cells were cultured in a nonluteinizing serum-free culture system, and challenged with DON or DOM-1 for 4 days to measure steroidogenesis and apoptosis, for 1-8 h to measure immediate-early genes, and for 5-60 min to measure phosphorylation of intracellular signaling proteins. Addition of DON decreased progesterone secretion at doses as low as 0.5 ng/ml but had no effect on testosterone secretion. Addition of DOM-1 inhibited progesterone and testosterone secretion at 0.5 ng/ml. Treatment of cells with 1 ng/ml DOM-1 increased the proportion of apoptotic cells, whereas DON had no effect. Addition of DON or DOM-1 stimulated phosphorylation of EIF2AK2, MAPK3/1, and AKT. However, DON inhibited and DOM-1 stimulated MAPK14 phosphorylation. DON increased the levels of mRNA encoding early-immediate genes EGR1, EGR3, and FOS, whereas DOM-1 was without effect. DOM-1 but not DON increased abundance of mRNA of the endoplasmic reticulum (ER) stress-related proteins, PRKRA and ATF4. We conclude that DOM-1 has a major impact on theca function in cattle, and possibly induces theca cell apoptosis through ER stress.
Introduction
Contamination of animal feed with Fusarium fungi is a common occurrence in many parts of the world and leads to the accumulation of mycotoxins including zearalenone (ZEN) and deoxynivalenol (DON) [1, 2] . ZEN is a highly estrogenic compound, and ingestion has major repercussions for the reproductive system. Pigs are particularly sensitive to ZEN, and intoxication leads to nymphomania, pseudopregnancy, and ovarian atrophy (reviewed in [3] ). ZEN has also been shown to reduce conception rates in cattle by decreasing the developmental competence of the oocyte [4] .
Deoxynivalenol is not estrogenic, but impacts cells by inducing the ribotoxic stress response (RSR). In the current model of DON action, DON binds to ribosomal RNA and induces autophosphorylation and activation of eukaryotic translation initiation factor 2 alpha kinase 2 (EIF2AK2; previously known as double-stranded RNAactivated protein kinase, PKR) [5] and Src family tyrosine kinase (HCK, also known as hematopoietic cell kinase) [6] . These events result in downstream activation of the p38 (MAPK14), ERK1/2 (MAPK3/1), and c-Jun N-terminal kinase (MAPK8) members of the mitogen-activated protein kinase (MAPK) family [7] .
The effects of DON on the reproductive system have not been studied as extensively as those of ZEN. Addition of DON to porcine oocyte-cumulus complexes inhibited cumulus expansion and oocyte maturation [8] [9] [10] , and DON has been reported to either increase or decrease estradiol and progesterone secretion from porcine granulosa cells in vitro [11] [12] [13] . It has recently been demonstrated that DON inhibits steroidogenesis in bovine granulosa cells and increases the rate of apoptosis in vitro [14, 15] , suggesting that DON may affect follicle growth in cattle. In bovine granulosa cells, DON activated MAPK3/1, MAPK8, and MAPK14, and stimulated abundance of immediate-early gene mRNA including that of early growth response 1 (EGR1), EGR3, FOS, and FOSL1 [14] . In ruminants, however, DON is metabolized to deepoxy-DON (DOM-1) in the rumen [16] , and DOM-1 is much less toxic for fibroblasts, lymphocytes, and intestinal cells [17] [18] [19] . Nevertheless, DOM-1 occurs in blood and in ovarian follicular fluid at concentrations greater than those of DON [20] , and its effects on the ovary warrant investigation.
Although the two somatic cell types of the follicle are critical for follicle health, granulosa, and theca cells, it is generally accepted that the granulosa cell layer is most affected by follicle atresia. Functional changes associated with atresia include a reduction in estradiol secretion [21, 22] and expression of the gene encoding cytochrome P450aromatase (CYP19A1), an enzyme critical for estradiol synthesis [23] . When antral follicles undergo atresia, the theca layer remains relatively unaffected [24] ; nevertheless, follicular estradiol secretion is entirely dependent on the production of androgens by the theca layer, suggesting that a toxin that alters theca function may have an impact on follicle development.
There are no studies to suggest whether mycotoxins affect theca cell function. The objectives of this study were to determine the effects of DON and of DOM-1 on theca cell steroidogenesis and apoptosis in a nonluteinizing serum-free culture system, and to determine the main pathways through which they act.
Materials and methods

Cell culture
All materials were obtained from Life Technologies Inc. (Thermo Fisher Scientific) unless otherwise stated. Bovine theca cells were cultured in serum-free conditions that maintain testosterone and progesterone secretion and responsiveness to luteinizing hormone (LH) [25] . Bovine ovaries were obtained from adult cows, independently of the stage of the estrous cycle at the slaughterhouse and transported to the laboratory at 30
• C in phosphate-buffered saline (PBS) containing penicillin (100 IU) and streptomycin (100 μg/ml). Follicles (4-6 mm diameter) were bisected within the ovarian stroma, gently scraped to remove granulosa cells, and the theca "shells" were peeled from the stroma with forceps. Pooled theca layers were incubated with collagenase (type IV, 1 mg/ml; SigmaAldrich) and trypsin inhibitor (100 μg/ml; Sigma-Aldrich) in a water bath at 37
• C for 45 min with agitation every 10 min. The resulting supernatant was filtered through a 150-mesh steel sieve (SigmaAldrich), centrifuged (800 g for 10 min), and the pellet was resuspended in PBS before being subjected to an osmotic shock treatment to remove red blood cells. After washing, cells were resuspended in McCoy 5A modified medium supplemented with 100 IU/ml penicillin, 100 μg/ml streptomycin, 1 μg/ml fungizone, 10 ng/ml bovine insulin, 2 mM L-glutamine, 10 mM HEPES, 5 μg/ml apotransferrin, 5 ng/ml sodium selenite, 0.1% bovine serum albumin (BSA) (all purchased from Sigma-Aldrich), and bovine LH (NIDDK). Cell viability was assessed by Trypan blue dye exclusion, seeded into 24-well tissue plates (Sarstedt Inc.) at a density of 250 000 viable cells in 1 ml, and cultured at 37
air for up to 6 days with 70% of the medium being replaced on days 2 and 4. A comparison of theca and granulosa cells was performed by recovering theca cells as above, and on subsequent occasions granulosa cells were recovered by scraping from the follicle wall and were cultured in 24-well tissue plates at a density of 500 000 viable cells in 500 μl minimum essential medium (MEM) containing sodium bicarbonate (10 mM), 25 mM HEPES, 4 ng/ml sodium selenite, 0.1% BSA (Sigma-Aldrich), penicillin (100 U/ml) androstenedione (10 −6 M), and bovine folliclestimulating hormone (FSH) (10 ng/ml starting on day 2, AFP5346D; National Hormone and Peptide Program, Torrance, CA, USA) [14] .
Cultures were maintained at 37
• C in 5% CO 2 , 95% air for up to 6 days with 70% of the medium being replaced on days 2 and 4. Theca cells were treated with 0, 0.005, 0.05, 0.5, and 1 ng/ml DON, and granulosa cells were treated with 0, 1, 10, and 100 ng/ml based on a previous study [14] .
Experimental treatments
Certified Biopure Standard grade DON and DOM-1 in acetonitrile were purchased from Romer Labs, and were reconstituted in methanol for cell culture studies. To determine the effects of mycotoxins on theca cell steroidogenesis, 0.005-100 ng/ml DON or DOM-1 (each in maximum volume of 1 μL methanol) or vehicle (1 μL methanol) was added to cells in the day 2 and day 4 medium changes, and cells and media were recovered on day 6. Apoptosis was measured with an Annexin V-FITC apoptosis detection kit (SigmaAldrich) after treating the cells with an effective dose of DON or of DOM-1 for 4 days.
To assess the effect of DON and of DOM-1 on intracellular pathway activation, a minimum effective dose (1 ng/ml) of DON or DOM-1 was added on day 5 of culture, without a medium change, for 0, 5, 15, 30, and 60 min, and cells were recovered in RIPA buffer to measure the phosphorylation status of key protein kinases. In further studies, cells were incubated for 1 h with pharmacological inhibitors of EIF2AK2 (C16, Sigma-Aldrich) or HCK (PP2; Santa Cruz Biotechnology) before adding DON or DOM-1. A preliminary dose-response study was performed for C16 (see Results section), and a minimally effective dose of 1 μM PP2 was employed [26] , which is lower than that previously used in granulosa cells [27, 28] .
The effect of DON or of DOM-1 on abundance of mRNA of immediate-early and endoplasmic reticulum (ER) stress genes was determined by treating cells on day 5 of culture with 1 ng/ml DON or DOM-1, without a medium change, for 0, 1, 2, 4, and 8 h. Cells were recovered for RNA extraction. Cells were recovered for RNA extraction. All experiments were performed with three different pools of cells each collected on a different occasion, and contained medium and vehicle (methanol) controls.
Steroid assay
Progesterone was measured in conditioned medium in duplicate as described [22, 29] with mean intra-and interassay coefficients of variation of 2.2% and 3.2%, respectively. Testosterone levels were measured in conditioned medium in duplicate by enzyme-linked immunosorbent assay (ELISA) using an anti-testosterone monoclonal antibody (M021812, Fitzgerald Industries), and mean intra-and interassay coefficients of variation were 2.3% and 8.7%. This antibody has <0.1% cross-reactivity with androstenedione and other steroids tested (manufacturer information). Steroid concentrations in the culture medium were corrected for cell number by expressing the data per unit mass of total cell protein. The sensitivity of these assays was 4 and 1.5 pg/ml for progesterone and testosterone, equivalent to 20 and 24 ng/μg protein, respectively.
Total RNA extraction and real-time PCR
After treatments, medium was removed and total RNA was extracted using Trizol according to the manufacturer's instructions. Total RNA (0.5 μg) was quantified by absorbance at 260 nm and treated with 1 U DNase (Invitrogen; Thermo Fisher Scientific). RNA was reverse transcribed in the presence of 1 mmol/L oligo (dT) primer and 4 U Omniscript RTase (Qiagen), 0.25 mmol/L dideoxynucleotide triphosphate mix, and 19.33 U RNase Inhibitor (GE Healthcare) in a volume of 20 μL at 37
• C for 1 h. The reaction was terminated by incubation at 93
• C for 5 min.
Real-time PCR was performed on a 7300 Real-Time PCR system (Applied Biosystems) with Power SYBR Green PCR Master Mix. Target genes (with reference to or sequence of primers) were the steroidogenic proteins STAR [30] , HSD3B1, HSD17B1, and CYP11A1 [31] , CYPA17A1 (forward: 5 -CCACG ATGGCACTTTCATAA-3 , reverse: 5 -TCACCAAGCATCTGG ACAG-3 ), POR (forward: 5 -TCATCACATGGCGAGAGCAG-3 , reverse: 5 -GTACTGGCGAATGCTGGACT-3 ); the immediateearly response genes EGR1, FOS, and FOSL [32] , EGR3 (forward:
5 -AGCGCGCTCAACCTCTTTT-3 ; reverse: 5 -GGTCAGACCGATGTCCATC-3 ); the cell health and apoptosisassociated proteins GADD45B [33] , FASLG [34] , and BID (forward: 5 -CTCCGTCCTGCTGCTCTTTC-3 ; reverse: 5 -GTGGACGGCCTTCACCG-3 ); the ER stress-related genes PRKRA (forward: 5 -GCAAGTATTTGCTTTGCAGTTCC-3 , reverse: 5 -CTCCCTCCTGGGAAAGGGTA-3 ) and ATF4 (forward: 5 -CTTAAGCCATGGCGCTTTTC -3 , reverse: 5 -GTTGCGAG-GTTTTGGTGCTT -3 ). Common thermal cycling parameters (3 min at 95
• C, 40 cycles of 15 s at 95
• C, 30 s at 59
• C, and 30 s at 72
• C) were used to amplify each transcript. Melting curve analyses were performed to verify product identity, and the novel amplicons were sequenced to verify authenticity. Samples were run in duplicate and were expressed relative to the histone H2AFZ [31] as housekeeping gene. Data were normalized to a calibrator sample using the Ct method with correction for amplification efficiency [35] .
Western blot
After challenge with DON/DOM-1, cells were washed with cold PBS and lysed in 100 μL/well cold RIPA buffer (25 mM Tris-HCl Ph 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS, 1 mM sodium orthovanadate, and protease inhibitor cocktail). The homogenate was centrifuged at 6000 g for 5 min at 4
• C. The • C. The loading control was ACTB (#47778; 1:1000; Santa Cruz Biotechnology). After washing three times with TTBS, membranes were incubated for 2 h at room temperature with 1:10 000 anti-rabbit HRP-conjugated IgG (GE Healthcare) diluted in TTBS. After five washes in TTBS, protein bands were revealed by chemiluminescence (Millipore ECL) with a gel imaging system (ChemiDoc XRS system; Bio-Rad). Semiquantitative analysis was performed with Bio-Rad ChemiDoc XRS software.
Statistical analysis
All statistical analyses were performed with JMP software (SAS Institute). Data were transformed to logarithms if they were not normally distributed (Shapiro-Wilk test). Where main effects were significant in ANOVA, the effect of time or treatment was tested with the Tukey-Kramer HSD test. The data are presented as least square means ± SEM.
Results
Effect on steroidogenesis
Theca cells cultured in the current conditions responded to LH with a significant increase in testosterone and progesterone secretion, and the addition of vehicle (methanol) did not alter this response ( Figure 1A ). An initial dose-response study with 1, 10, and 100 ng/ml DON or DOM-1 revealed that all doses completely suppressed progesterone secretion (not shown); as a consequence, a further doseresponse was performed with concentrations from 0.005 to 1 ng/ml. Addition of DON to theca cells significantly inhibited LH-stimulated progesterone secretion at 0.5 and 1 ng/ml, but had no effect on testosterone secretion. Treatment of cells with DOM-1 resulted in significant inhibition of progesterone and testosterone secretion at doses of 0.5 ng/ml and higher ( Figure 1A ). The response of theca cells to DON was compared to that of granulosa cells: the dose of DON required to achieve 33% reduction of progesterone secretion was from 100 and 0.5 ng/ml for granulosa cells and theca cells, respectively ( Figure 1B) . At the dose of 1 ng/ml, DON decreased abundance of STAR and HSD3B1 mRNA levels and DOM-1 decreased CYP11A1, STAR, HSD3B1, HSD17B1, and POR mRNA abundance (Figure 2 ). Neither treatment significantly altered CYP17A1 mRNA levels. Methanol alone did not alter abundance of mRNA of any gene measured.
Effect on apoptosis
Exposure of theca cells to DOM-1 increased the proportion of annexin positive apoptotic cells, and also increased abundance of mRNA encoding GADD45B, FASLG, and BID, proteins associated Figure 2 . Effect of mycotoxins on the abundance of mRNA encoding key steroidogenic proteins in bovine theca cells. Cells were cultured in serum-free medium for 6 days with medium changes on days 2 and 4. From day 2, cells were cultured with LH (control), LH plus methanol (MeOH), or LH plus DON or DOM-1 (1 ng/ml). Total RNA was recovered on day 6 for analysis by real-time PCR. Data are presented as means ± SEM of three independent culture replicates; asterisks indicate means that are significantly different from control (P < 0.05). Cells were cultured in serum-free medium for 6 days with medium changes on days 2 and 4. From day 2, cells were cultured with LH (control), LH plus methanol (MeOH), or LH plus DON or DOM-1 (1 ng/ml). Apoptosis was assessed with the Annexin apoptosis kit (A), and abundance of mRNA encoding pro-apoptotic proteins was measured by real-time PCR (B). Data are presented as means ± SEM of three independent culture replicates; asterisks indicate means that are significantly different from control (P < 0.05).
with apoptosis. Addition of DON did not increase the proportion of apoptotic cells or GADD45B or FASL mRNA levels, but did increase the levels of BID mRNA (Figure 3 ).
Signaling pathways activated by DON and DOM-1
The intracellular signaling pathways activated by DON and by DOM-1 in theca cells were investigated by western blotting. Addition of either DON or DOM-1 increased phospho-EIF2AK2 levels within 15 or 5 min, respectively, and phosphorylation remained elevated for at least an hour ( Figure 4A ). Addition of DON caused a rapid (within 5 min) and transient (return to baseline by 30 min) increase in MAPK3/1 phosphorylation, whereas DOM-1 resulted in a weaker but more sustained phosphorylation of MAPK3/1 (Figure 4B ). DON and DOM-1 had opposite effects on activation of MAPK14; DON decreased pMAPK14 levels, whereas DOM-1 increased pMAPK14 levels ( Figure 4C ). The inhibition of pMAPK14 levels by DON was specific, as treatment with methanol control did not alter pMAPK14 levels over this time course (Supplemental Figure S1) .
Addition of either DON or DOM-1 increased phosphorylation of AKT, although the timing differed between treatments; DON increased pAKT at 15 min, whereas DOM-1 increased pAKT at 5 min only ( Figure 4D ). Both mycotoxins transiently stimulated the phosphorylation of MAPK8 at 30 min post-treatment ( Figure 4E ).
The importance of the RSR for the downstream effects of DON and DOM-1 was tested with the addition of EIF2AK2 (C16) or HCK (PP2) inhibitors. Preliminary experiments demonstrated effective inhibition of EIF2AK2 phosphorylation by 1 μg/ml C16 ( Figure 5A ). Addition of DOM and of DOM-1 increased MAPK3/1 phosphorylation as before, and this was abolished by pretreatment with C16 ( Figure 5B ). Treatment of cells with DON decreased pMAPK14 levels and DOM-1 increased pMAPK14 levels, as before, and pretreatment with C16 increased pMAPK14 levels in both cases ( Figure 5B) .
In a subsequent study, we used the HCK inhibitor PP2, which had no effect on DON or DOM-1 stimulated EIF2AK2 phosphorylation, but abolished the ability of DON or DOM-1 to stimulate MAPK3/1 phosphorylation ( Figure 6 ). Pretreatment with PP2 significantly suppressed MAPK14 phosphorylation to levels significantly lower than controls irrespective of the mycotoxin present ( Figure 6 ).
Addition of DON resulted in a rapid and transient increase in the levels of mRNA of the immediate-early genes EGR1, EGR3, and FOS, and a decrease in FOSL1 mRNA abundance (Figure 7) . Treatment with DOM-1 had no effect on the abundance of these mRNAs. Finally, abundance of mRNA encoding the ER stress-related proteins PRKRA and ATF4 was measured; DOM-1 increased ATF4 mRNA levels at 1, 2, and 4 h and increased PRKRA mRNA levels at 8 h, whereas DON had no effect or inhibited mRNA abundance ( Figure 7) .
Discussion
This study reveals several novel and striking findings on the impact of DON and DOM-1 on theca cell function in cattle. These include the unexpected sensitivity of theca cells to DON and DOM-1, the proapoptotic effects of DOM-1 on theca cells, and the likely mechanism of action of DOM-1 through ER stress.
The deleterious effects of DON on numerous cell types are well known. In the ovary, DON has been shown to inhibit granulosa cell function (steroidogenesis) and health in cattle at relatively high doses (30-100 ng/ml) [14, 15] . Theca cells are not generally considered to be affected by follicle atresia [24] ; therefore, it was surprising to observe that theca cells are highly sensitive to DON, with an inhibition of progesterone secretion occurring at a dose 100-fold lower than that required with granulosa cells ( [14] and this study). It is unlikely that the difference in sensitivity between cell types in this study was artifactual as the same stock solutions of DON were used for both cell types and the progesterone measurements were performed in the same assay; however, we cannot rule out the possibility that differences in base medium (McCoy vs MEM) or supplements (LH Figure 4 . Intracellular pathways activated by DON and DOM-1 in bovine theca cells. Cells were cultured in serum-free medium with medium changes on days 2 and 4, and on day 5 DON (black bars) or DOM-1 (gray bars) were added (1 ng/ml) for the times given. Total cell protein was recovered, and abundance of phosphorylated EIF2AK2 (A), MAPK3/1 (B), MAPK14 (C), AKT (D), and MAPK8 (E) was measured by western blotting. Phosphorylated protein was expressed relative to total protein, except for PKR and AKT which were expressed relative to ACTB. Data are presented as means ± SEM of three independent culture replicates; bars without common letters are significantly different (P < 0.05). Figure 5 . Role of EIF2AK2 in DON and DOM-1 action on theca cells. Cells were cultured in serum-free medium with medium changes on days 2 and 4, and on day 5 DOM-1 (1 ng/ml) was added with or without pretreatment with 0, 0.1, 1, or 10 μM EIF2AK2 inhibitor (C-16) for 1 h (A). In subsequent experiments, cells were pretreated with 1 μ M inhibitor for 1 h before adding DON or DOM-1 for 15 min (B). Total cell proteins were recovered for western blot analysis for abundance of EIF2AK2, MAPK3/1, and MAPK14 phosphorylation. Data are presented as means ± SEM of three independent culture replicates; bars without common letters are significantly different (P < 0.05). Effect of DON or DOM-1 on immediate-early gene and ER stress mRNA levels in theca cells. Cells were cultured in serum-free medium with medium changes on days 2 and 4, and on day 5 DON or DOM-1 was added (1 ng/ml) for the times given. Total RNA was recovered for analysis by real-time PCR. Data are presented as means ± SEM of three independent culture replicates; asterisks indicate means that are significantly different from control (P < 0.05). vs FSH) altered the responses of cells to mycotoxin. The reduction in steroid secretion from theca cells was logically accompanied by decreases in levels of mRNA encoding proteins essential for progesterone production, STAR and HSD3B1. The progestagenic pathway involves the importation of cholesterol into mitochondria by STAR, conversion to pregnenolone by CYP11A1 and then to progesterone by HSD3B1 (see [36] for a detailed description of the steroidogenic pathway). A reduction in STAR and HSD3B1 proteins would reduce the levels of cholesterol and the conversion of pregnenolone to progesterone, even in the presence of adequate CYP11A1 levels.
More surprising however was the dramatic reduction of progesterone and of testosterone secretion caused by DOM-1. The decrease in steroid secretion was accompanied by a decrease in the abundance of not only STAR and HSD3B1 mRNA, as observed for DON, but also of CYP11A1, HSD17B1, and POR mRNA. The enzyme HSD17B1 catalyzes the conversion of androstenedione to testosterone, and the cytochrome P450 reductase POR is important for the catalytic activity of CYP17A1 [37] ; the reduction of testosterone secretion by DOM-1 was likely an effect of reduced levels/activity of HSD17B1, POR, or both. We are unaware of any other reports demonstrating an inhibitory effect of DOM-1 on endocrine function in any cell type.
Equally surprising was the increase in apoptosis of theca cells caused by DOM-1. This is in contrast to studies with mouse 3T3 fibroblast and porcine intestinal epithelial cell lines, and in porcine peripheral blood mononuclear cells in which DOM-1 did not affect cell viability [17, 19] . Explanations for the difference between studies may include animal species, cell type, and culture systems used (with or without serum). The increase in the proportion of apoptotic theca cells caused by DOM-1 was accompanied by an increase in abundance of GADD45B and FASLG mRNA levels. FASLG is a major 'death ligand' that binds to the receptor FAS; the involvement of FASLG in inducing apoptosis in granulosa cells is well known [38] , and DON potentiates FAS-induced apoptosis in leukocytes [39] . The role of GADD45B is unclear as it has been shown to either mediate FAS-induced apoptosis in hepatocytes [40] or to repress FAS-induced apoptosis in lymphocytes [41] . The inability of DON to induce apoptosis in this is likely a question of dose, as less than 100 ng/ml failed to alter viability in several cell types [19, 42] .
As DOM-1 is generally considered to be nontoxic, little attention has been paid to the mechanism of action of this molecule. In this study, both DON and DOM-1 activated EIF2AK2, MAPK3/1, and AKT, which is fully expected for DON [5, 7, 43] but not previously described for DOM-1. However, the effects of DON and DOM-1 on MAPK14 phosphorylation were not expected. It is generally accepted that DON increases pMAPK14 levels at doses typically above 100 ng/ml [44] , although studies with doses between 25 and 50 ng/ml DON show weak effects on MAPK14 activation [45, 46] . The inhibitory effect of DON on MAPK14 phosphorylation observed in this study may be an effect of very low concentrations of DON (1 ng/ml). In contrast, this same dose of DOM-1 increased MAPK14 phosphorylation in this study, which has not been previously reported. Recently, Pierron and colleagues showed that DOM-1 had no effect on MAPK14 phosphorylation in porcine jejunal explants and the Caco-2 human intestinal cell line [18] ; the discrepancies between our study and that of Pierron et al. may be caused by the different doses of DOM-1 used (1 ng/ml compared with 2800 ng/ml), the different cell types, and/or different species used.
The activation of EIF2AK2 and HCK was necessary for the activation of downstream pathways by DOM-1 as it was for DON, as treatment with an EIF2AK2 inhibitor or a HCK inhibitor blocked the ability of either to phosphorylate MAPK3/1, and blocking HCK suppressed MAPK14 phosphorylation as previously reported [47] . Treating cells with the imidazole-oxindole EIF2AK2 inhibitor C16 increased pMAPK14 levels irrespective of treatment, which suggests a nonspecific action of this inhibitor. The inability of the HCK inhibitor to decrease EIF2AK2 phosphorylation shows that HCK activation is downstream or independent of EIF2AK2.
Activation of these pathways by DON resulted in increased abundance of mRNA encoding the early-immediate genes EGR1, EGR3, and FOS, which is consistent with previous studies with ovarian granulosa, intestinal epithelial, and hepatoma cells [14, 48, 49] . However, as for all the other effects noted here, theca cells are more sensitive than granulosa cells to DON; in granulosa cells, DON stimulation of EGR1, EGR3, or FOS mRNA levels was observed at 100 ng/ml but not at 1 ng/ml [14] . In contrast to the effects of DON, DOM-1 failed to alter levels of mRNA transcripts of these genes, and this is most likely owing to differences in the pattern of MAPK3/1 activation by DON (strong and transient) and DOM-1 (weaker and sustained); several studies suggest that transient vs sustained MAPK3/1 activation leads to distinct cell responses [50] [51] [52] .
In the currently understood mechanism of action of DON, this toxin interacts with ribosomal RNA and alters its secondary and/or tertiary structure and thereby activating EIF2AK2 [5] ; however, DOM-1 lacks the epoxide group necessary for efficient activation of ribosome-dependent MAPK signaling [18] . An alternative mechanism may involve ER stress, which has been shown to increase PRKRA mRNA levels and to activate EIF2AK2 through PRKRA without involving the ribosome [53, 54] . Activated EIF2AK2 may then increase ATF4 mRNA and protein levels, leading to ER stress-induced apoptosis [55] . The increase PRKRA mRNA levels, EIF2AK2 phosphorylation, and ATF4 mRNA levels observed in this study after treatment with DOM-1 are entirely consistent with activation of ER stress; a hypothetical model of DOM-1 action is illustrated in Figure 8 .
In conclusion, this study identifies a biological action of DOM-1 on ovarian theca cells in vitro. DOM-1 activates EIF2AK2, most likely through ER stress and PRKRA activity independently of the ribosome, which leads to activation of EIF2AK2, a low but sustained increase in MAPK3/1 phosphorylation and activation of MAPK14. This stimulates apoptosis and loss of steroid secretory function. Although it has not yet been determined if DOM-1 affects follicle growth in vivo, it may be unwise to dismiss DOM-1, even at levels as low as 1 ng/ml, as an inactive metabolite of DON with no deleterious effects on organ systems.
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Supplemental Figure S1 . Stability of MAPK14 phosphorylation in bovine theca cells in vitro. Cells were cultured in serum-free medium with medium changes on days 2 and 4, and on day 5 methanol vehicle was added for the times given. Total cell protein was recovered and abundance of phosphorylated and total MAPK14 was determined by western blotting. Phosphorylated protein was expressed relative to total protein. Data are presented as means ± SEM of three independent culture replicates.
